Unknown

Dataset Information

Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.


ABSTRACT:

SUBMITTER: Canales MA 

PROVIDER: S-EPMC10065834 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature